BRAF mutations in melanocytic tumors (nevi and melanomas) from organ transplant recipients

European Journal of Dermatology

Volumn 20, Issue 2, 2010, Pages 167-171

  Kanitakis, Jean ^a   Baldassini, Sylvie ^a   Lora, Viviana ^a   Euvrard, Sylvie ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

B RAF V600E; B RAF mutation; Melanocytic nevi; Melanoma; Organ transplantation

Indexed keywords

B RAF KINASE; DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MUTATION RATE; NEVUS; ORGAN TRANSPLANTATION; POSTOPERATIVE PERIOD; RECIPIENT; SCHOOL CHILD; SKIN CARCINOGENESIS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MUTATION; NEVUS; ORGAN TRANSPLANTATION; PROTO-ONCOGENE PROTEINS B-RAF; RETROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA; SKIN NEOPLASMS; YOUNG ADULT;

EID: 77950372130     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.0843     Document Type: Article

References (26)

1. E600 in benign and malignant human tumours. Oncogene 2008; 27: 877-895
2. Davies H, Bignell G, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417: 949-954
3. Pollock P, Harper U, Hansen K, et al. High frequency of BRAF mutations in nevi. Nat Genet 2003; 33: 19-20.
4. Poynter J, Elder J, Fullen D, et al. BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res 2006; 16: 267-273
5. Saldanha G, Purnell D, Fletcher A, Potter L, Gilies A, Pringle H. High BRAF mutation frequency does not characterize all melanocytic tumor subtypes. Int J Cancer 2004; 111: 705-710
6. 600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. J Invest Dermatol 2006; 126: 2111-2118
7. Kumar R, Sabrini A, Snellman E, Hemminki K. BRAF mutations are common somatic events in melanocytic nevi. J Invest Dermatol 2004; 122: 342-348
8. Lang J, McKie R. Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes. J Invest Dermatol 2005; 125: 575-579
9. Loewe J, Kittler H, Fischer G, Faé I, Wolff K, Petzelbauer P. BRAF kinase gene V599E mutations in growing melanocytic lesions. J Invest Dermatol 2004; 123: 733-736
10. Maldonado J, Fridlyand J, Patel H, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 2003; 95: 1878-1890
11. Thomas NE. BRAF somatic mutations in malignant melanoma and melanocytic naevi. Melanoma Res 2006; 16: 97-103.
12. Uribe P,Wistuba I, Gonzalez S. BRAF mutation. A frequent event in benign, atypical, and malignant melanocytic lesions of the skin. Am J Dermatopathol 2003; 25: 365-370
13. Yazdi A, Palmedo G, Flaig M, et al. Mutations of the BRAF gene in benign and malignant melanocytic lesions. J Invest Dermatol 2003; 121: 1160-1162
14. Edlundh-Rose E, Egyhazi S, Omholt K, et al. NRAS and BRAF mutations in melanoma tumors in relation to clinical characteristics: a study based on mutation screening by pyrosequencing. Melanoma Res 2006; 16: 471-478
15. Omholt K, Platz A, Kanter L, Ringborg U, Hansson J. NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. Clin Cancer Res 2003; 9: 6483-6488
16. Dong J, Phelps R, Qiao R, et al. BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. Cancer Res 2003; 63: 3883-3885
17. Turner D, Zirvi M, Barany F, Elenitsas R, Seykora J. Detection of the BRAF V600E mutation in melanocytic lesions using the ligation detection reaction. J Cutan Pathol 2005; 32: 334-339
18. Casula M, Colombino M, Satta MP, et al. BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup Study. J Clin Oncol 2004; 22: 286-292
19. Murphy G. Skin diseases with high public health impact. Melanoma. Eur J Dermatol 2007; 17: 559-562
20. Smith C, McGregor J, Barker J, Morris R, Rigden S, MacDonald D. Excess melanocytic nevi in children with renal allografts. J Am Acad Dermatol 1993; 28: 51-55
21. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681-1691
22. Alaibac M, Piaserico S, Rossi C, et al. Eruptive melanocytic nevi in patients with renal allografts: report of 10 cases with dermoscopic findings. J Am Acad Dermatol 2003; 49: 1020-1022
23. Matin R, Mesher D, Proby C, et al. Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases. Am J Transplant 2008; 8: 1891-1900
24. Mihic-Probst D, Perren A, Schmid S, Saremaslani P, Kommijoth P, Heitz P. Absence of BRAF gene mutations differentiates Spitz nevi from malignant melanoma. Anticancer Res 2004; 24: 2415-2418
25. Gill M, Renwick N, Silvers D, Celebi JT. Lack of BRAF mutations in Spitz nevi. J Invest Dermatol 2004; 126: 1325-1326
26. Guba M, Graeb C, Jauch KW, Geissler EK. Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 2004; 77: 1777-1782